Nine Korean and foreign venture capital firms and financial institutions invested a total of 35 billion won ($23.7 million) in medical AI company AITRICS, the company announced Monday, marking the com ...

The government has unveiled a large-scale overhaul of the health insurance drug pricing system, proposing flexible ...

Celltrion said it secured formulary placement for its bone-disease treatments Stoboclo and Osenvelt (ingredient: denosumab) ...

The impact of the Tattoo Artist Act, enacted last October, has been confirmed. A guilty verdict handed down in July for ...

Huons Meditech, a medical device subsidiary of Huons Group, said Monday it launched the Dermashine Duo RF, combining precise drug delivery with radiofrequency (RF) technology to enable a variety of fa ...

Ybrain, a mental-health electroceutical platform company, said Monday it has begun full-scale sales of Somzz, a digital therapeutic device (DTx) for insomnia, reinforcing its sleep-care business platf ...

Recent five-year results presented at the European Society for Medical Oncology (ESMO 2025) showed that perioperative ...

The government will launch a large-scale overhaul of the drug pricing system starting in the second half of 2026, lowering ...

Dong-A ST said it launched its new benign prostatic hyperplasia (BPH) treatment Dutana in Korea on Friday. Dutana combines 0.5 mg of dutasteride and 5 mg of tadalafil in a single once-daily tablet.

Professor Je Hyung-gon (Courtesy of SNUBH)A recent study highlights minimally invasive heart valve surgery as a safer alternative to conventional open-chest surgery, offering patients improved safety ...

Hemophilia, a rare genetic bleeding disorder once synonymous with lifelong transfusions, is undergoing a profound shift.